Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures

Experimental Dermatology

Volumn 13, Issue 3, 2004, Pages 129-139

  Ständer, Sonja ^a,e   Moormann, Corinna ^a   Schumacher, Mark ^b   Buddenkotte, Jörg ^a   Artuc, Metin ^c   Shpacovitch, Victoria ^a   Brzoska, Thomas ^a   Lippert, Undine ^d   Henz, Beate M ^c   Luger, Thomas A ^a   Metze, Dieter ^a   Steinhoff, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Capsaicin; Cutaneous nerve fibers; Pruritus; TRPV1; Vanilloid receptor subtype 1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; MESSENGER RNA; NEUROPEPTIDE; RECEPTOR SUBTYPE; SUBSTANCE P; VANILLOID RECEPTOR 1;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPITHELIUM CELL; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; KERATINOCYTE; MAST CELL; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; PRURIGO; PRURITUS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEBACEOUS GLAND; SENSORY NERVE CELL; SKIN APPENDAGE DISEASE; SKIN BLOOD VESSEL; SKIN EPITHELIUM; SKIN NERVE; SWEAT GLAND; URTICARIA PIGMENTOSA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOPSY; BRAIN; CALCITONIN GENE-RELATED PEPTIDE; CAPILLARIES; CAPSAICIN; CELL LINE; CHILD; ECCRINE GLANDS; EPIDERMIS; EPITHELIAL CELLS; GENE EXPRESSION; HAIR FOLLICLE; HUMANS; MAST CELLS; MIDDLE AGED; NERVE FIBERS; NEURONS, AFFERENT; NOCICEPTORS; PRURITUS; RATS; RECEPTORS, DRUG; SEBACEOUS GLANDS; SPINAL CORD; SUBSTANCE P;

EID: 12144287525     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.0178.x     Document Type: Article

References (60)

1. Surh Y J, Lee S S. Capsaicin, a double-edged sword: Toxicity, metabolism, and chemopreventive potential. Life Sci 1995: 56: 1845-1855.
2. Caterina M J, Schumacher M A, Tominaga M, Rosen T A, Levine J D, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997: 389: 816-824.
3. Caterina M J, Julius D. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 2001: 24: 487-517.
4. Zygmunt P M, Petersson J, Andersson D A et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999: 400: 452-457.
5. Smart D, Gunthorpe M J, Jerman J C et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000: 129: 227-230.
6. Szolcsányi J. Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol Sci 2000: 21: 41-42.
7. Di Marzo V, Bisogno T, De Petrocellis L. Anandamide: Some like it hot. Trends Pharmacol Sci 2001: 22: 346-349.
8. Tominaga M, Caterina M J, Malmberg A B et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998: 21: 531-543.
9. Sasamura T, Kuraishi Y. Peripheral and central actions of capsaicin and VR1 receptor. Jpn J Pharmacol 1999: 80: 275-280.
10. Di Marzo V, Bisogno T, De Petrocellis L et al. Highly selective CB (1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor 'hybrid' ligands. Biochem Biophys Res Commun 2001: 281: 444-451.
11. Huang S M, Bisogno T, Trevisani M et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002: 99: 8400-8405.
12. Holzer P. Capsaicin: Cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 1991: 43: 143-201.
13. Walpole C S, Bevan S, Bovermann G et al. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem 1994: 37: 1942-1954.
14. Szallasi A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand Suppl 1995: 629: 1-68.
15. 2). Life Sci 1996: 59: 105-117.
16. Schumacher M A, Moff I, Sudanagunta S P, Levine J D. Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes. J Biol Chem 2000: 275: 2756-2762.
17. Delany N S, Hurle M, Facer P et al. Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol Genomics 2001: 4: 165-174.
18. Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol 2002: 118: 110-121.
19. Szallasi A, Nilsson S, Farkas-Szallasi T, Blumberg P M, Hokfelt T, Lundberg J M. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 1995: 703: 175-183.
20. 3 purinoceptor and IB4 binding site. Eur J Neurosci 1999: 11: 946-958.
21. Mezey E, Toth Z E, Cortright D N et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000: 97: 3655-3660.
22. Ma Q P. Vanilloid receptor homologue, VRL1, is expressed by both A- and C-fiber sensory neurons. Neuroreport 2001: 12: 3693-3695.
23. Cortright D N, Crandall M, Sanchez J F, Zou T, Krause J E, White G. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun 2001: 281: 1183-1189.
24. Inoue K, Koizumi S, Fuziwara S, Denda S, Inoue K, Denda M. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 2002: 291: 124-129.
25. Southall M D, Li T, Gharibova L S, Pei Y, Nicol G D, Travers J B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003: 304: 217-222.
26. Denda M, Fuziwara S, Inoue K et al. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 2001: 285: 1250-1252.
27. Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001: 44: 471-478.
28. Artuc M, Steckelings U M, Henz B M. Mast cell-fibroblast interactions: Human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002: 118: 391-395.
29. Butterfield J H, Weiler D, Dewald G, Gleich G J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988: 12: 345-355.
30. Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002: 109: 787-798.
31. Ichikawa H, Sugimoto T. VRL-1 immunoreactivity in the rat cranial autonomic ganglia. Neuroreport 2001: 12: 1597-1599.
32. Jessell T M, Iversen L L, Cuello A C. Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 1978: 152: 183-188.
33. Bevan S, Szolcsányi J. Sensory neuron-specific actions of capsaicin: Mechanisms and applications. Trends Pharmacol Sci 1990: 11: 330-333.
34. Docherty R J, Robertson B, Bevan S. Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture. Neuroscience 1991: 40: 513-521.
35. Lotti T, Teofoli P, Tsampau D. Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 1994: 30: 232-235.
36. Al'Abadie M S K, Senior H J, Bleehen S S, Gawkrodger D J. Neuronal marker and neuropeptide studies in nodular prurigo. Eur J Dermatol 1994: 4: 154-158.
37. Ständer S, Metze D. Treatment of pruritic and painful skin diseases with topical capsaicin. In: Yosipovitch G, Greaves M, Fleischer A, McGlone F, eds. New concepts in itch 2004 (in press).
38. Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 1967: 31: 138-151.
39. Buck S H, Burks T F. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986: 38: 179-226.
40. Cappugi P, Tsampau D, Lotti T. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int J Dermatol 1992: 31: 206-209.
41. Green B G, Shaffer G S. The sensory response to capsaicin during repeated topical exposures: Differential effects on sensations of itching and pungency. Pain 1993: 53: 323-334.
42. Fox A J. Mechanisms and modulation of capsaicin activity on airway afferent nerves. Pulm Pharmacol 1995: 8: 207-215.
43. Luger T A. Neuromediators - a crucial component of the skin immune system. J Dermatol Sci 2002: 30: 87-93.
44. Biro T, Maurer M, Modarres S et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood 1998: 91: 1332-1340.
45. Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki B M. Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol 1981: 61: 465-469.
46. Bunker C B, Cerio R, Bull H A, Evans J, Dowd P M, Foreman J C. The effect of capsaicin application on mast cells in normal human skin. Agents Actions 1991: 33: 195-196.
47. Reynier-Rebuffel A M, Mathiau P, Callebert J et al. Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells. Am J Physiol 1994: 267: R1421-R1429.
48. Paus R, Heinzelmann T, Schultz K D, Furkert J, Fechner K, Czarnetzki B M. Hair growth induction by substance P. Lab Invest 1994: 71: 134-140.
49. Weidner C, Klede M, Rukwied R et al. Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J Invest Dermatol 2000: 115: 1015-1020.
50. Steinhoff M, Vergnolle N, Young S H et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000: 6: 151-158.
51. Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin. J Neurosci 2003: 23: 6176-6180.
52. Gabor M, Razga Z. Development and inhibition of mouse ear oedema induced with capsaicin. Agents Actions 1992: 36: 83-86.
53. Premkumar L S, Ahern G P. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000: 408: 985-990.
54. De Petrocellis L, Harrison S, Bisogno T et al. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001: 77: 1660-1663.
55. Jensen P K, Norgard J O, Knudsen C, Nielsen V, Bolund L. Effects of extra- and intracellular calcium concentration on DNA replication, lateral growth, and differentiation of human epidermal cells in culture. Virchows Arch B Cell Pathol Incl Mol Pathol 1990: 59: 17-25.
56. Bikle D D, Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr Rev 1993: 14: 3-19.
57. Bikle D D, Ratnam A, Mauro T, Harris J, Pillai S. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 1996: 97: 1085-1093.
58. Komuves L, Oda Y, Tu C L et al. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 2002: 192: 45-54.
59. Marks J G Jr. Treatment of apocrine chromhidrosis with topical capsaicin. J Am Acad Dermatol 1989: 21: 418-420.
60. Caterina M J, Leffler A, Malmberg A B et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000: 288: 306-313.